Health Canada has authorized a made-in-Canada COVID-19 vaccine from Medicago, known as Covifenz.
The two-dose, plant-based vaccine is authorized for use in people aged 18 to 64.
A sign for a vaccination clinic is shown in Moncton, New Brunswick on Jan. 14, 2022. THE CANADIAN PRESS/Ron Ward
|Updated:
The Canadian Press
Author
Author’s Selected Articles
